SCHEMBL16701255

SCHEMBL16701255

CC(O)C(NC(=O)C1CCCN1C(=O)C(N)CCCCN)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.52
DPP4 P27487 4/20 0.51
DPP7 Q9UHL4 4/20 0.51
DPP8 Q6V1X1 4/20 0.51
DPP9 Q86TI2 2/20 0.51
FAP Q12884 1/20 0.51
OPRM1 P35372 1/20 0.46
NTSR2 O95665 4/20 0.45
NTSR1 P30989 4/20 0.45
SORT1 Q99523 4/20 0.45
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
F2 P00734 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16701229 1.00 XIAP (0.52) XIAPDPP4DPP7DPP8DPP9
SCHEMBL16701230 1.00 XIAP (0.52) XIAPDPP4DPP7DPP8DPP9
SCHEMBL20740209 1.00 XIAP (0.52) XIAPDPP4DPP7DPP8DPP9
SCHEMBL16702238 1.00 XIAP (0.52) XIAPDPP4DPP7DPP8DPP9
SCHEMBL16702590 1.00 XIAP (0.52) XIAPDPP4DPP7DPP8DPP9
SCHEMBL29350414 0.93 XIAP (0.56) XIAPDPP4DPP7DPP8DPP9
SCHEMBL31206270 0.90 XIAP (0.66) XIAPDPP4DPP7DPP8DPP9
SCHEMBL29801899 0.88 DPP4 (0.54) XIAPDPP4DPP7DPP8DPP9
SCHEMBL29530800 0.87 XIAP (0.54) XIAPDPP4DPP7DPP8DPP9
SCHEMBL30490609 0.86 DPP4 (0.50) XIAPDPP4DPP7DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10383911-B2 Storage stable lyophilized tripeptide formulations DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2019-08-20 US claimed
EP-3065756-B1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR AUGUST WOLFF GMBH & CO KG ARZNEIMITTEL (DE) 2019-02-20 EP claimed
US-20160279188-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2016-09-29 US claimed
EP-3065756-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) 2016-09-14 EP claimed
WO-2015067493-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-05-14 WO claimed
US-10383911-B2 Storage stable lyophilized tripeptide formulations DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2019-08-20 US disclosed
US-10383911-B2 Storage stable lyophilized tripeptide formulations DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2019-08-20 US disclosed
EP-3065756-B1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR AUGUST WOLFF GMBH & CO KG ARZNEIMITTEL (DE) 2019-02-20 EP disclosed
US-20160279188-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2016-09-29 US disclosed
EP-3065756-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) 2016-09-14 EP disclosed
EP-3065756-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) 2016-09-14 EP disclosed
WO-2015067493-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-05-14 WO disclosed
WO-2015067493-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160279188-A1 STORAGE STABLE LYOPHILIZED TRIPEPTIDE FORMULATIONS PTMS, ITCH, PREP XIAP 194/4885DPP4 1047/4885DPP7 1239/4885
US-10383911-B2 Storage stable lyophilized tripeptide formulations PTMS, ITCH, PREP XIAP 194/4885DPP4 1047/4885DPP7 1239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.